The Texas Department of State Health Services-Radiation Control Program has granted Positron's wholly owned subsidiary, Manhattan Isotope Technology, approval of its radioactive materials license amendment.
Shine Medical Technologies, a developer of medical isotopes and cancer treatment elements, intends to build a new manufacturing plant in Janesville, Wis. Plant completion is planned for 2015, with more than 100 permanent employees and potential for further employment growth.
The Dutch Ministry of Economic Affairs, Agriculture and Innovation has announced that the government's cabinet views the realization of a new PALLAS nuclear reactor "postively," which is an "important condition for further progress on the PALLAS project," according to a statement from the Nuclear Research & Consultancy Group.
Positron has acquired all of the assets and business operations and retained all employees of Manhattan Isotope Technology (MIT). In exchange, MIT will receive cash advances, assumption of certain indebtedness and earn-out consideration of $3.5 million, based on 20 percent of the net income from sales relating to radioisotope and radiopharmaceutical operations of MIT.
Nordion has reported increases in net income and revenue for the fiscal year (FY) 2011, despite losses in the fourth quarter. Also, the company made its predictions for how its isotopes unit will perform in FY2012.
McMaster University in Hamilton, Ontario, has unveiled its newly expanded Nuclear Research Building, which includes a new cyclotron facility and improvements to the McMaster Nuclear Reactor (MNR) Building.
Advanced Medical Isotope Corporation (AMIC), a developer and distributor of medical isotopes, has entered into a strategic relationship with Spivak Management and Mann Healthcare Partners to form a joint venture to develop and execute AMIC's business strategy.
Eckert & Ziegler, a German-based isotope company, has acquired the radiopharmaceutical equipment business of Washington, D.C.-based Bioscan.
Positron, a nuclear cardiology company, has executed a memorandum of understanding with the City of Noblesville, Ind., to relocate its corporate headquarters, research & development and product manufacturing facilities to Noblesville.
Shine Medical Technologies, a Middleton, Wis.-based startup, has secured an initial $11 million in venture capital funding as part of its bid to develop a manufacturing plant that will assist with the shortage of medical isotopes.
The Atomic Energy of Canada Limited has reported that its Chalk River Laboratories will undergo a 33-day planned outage, which began on May 15 as part of its ongoing operations of the National Research Universal nuclear reactor.
Written by Justine Cadet
The current crisis of the Japanese nuclear reactors as a result of the natural disasters should have “a fairly small impact on the U.S. attempts to develop medical isotopes domestically,” Robert W. Atcher, PhD, MBA, leader of the medical isotope task force and past-president of the Society of Nuclear Medicine (SNM), explained in an interview.
Tokamak Solutions has received more than $323,000 in contracts and investments toward the development of a super compact tokamak, a fusion neutron source, in part for the production of medical isotopes for the diagnosis and treatment of cancers.
Sen. Jeff Bingaman (D-N.M.), chair of the Senate Committee on Energy and Natural Resources, and Sen. Lisa Murkowski (R-Ark.) have introduced the American Medical Isotopes Production Act of 2011 (S 99), which aims to promote sustainable, domestic production of the medical isotope molybdenum-99 (Mo-99).
|
RSS 
